Press Releases

 Filter by Provider

Thunder Bay, Ontario--(Newsfile Corp. - October 26, 2026) - Thunder Gold Corp. (TSXV: TGOL) (FSE: Z25) (OTCQB: TGOLF) ("Thunder Gold" or the "Company") is pleased to announce the following infill diamond drill results from the Bench Target, at the Company's flagship Tower Mountain Property, 40 kilometres west of Thunder Bay, Ontario.

DesignRush recognized MCH Strategic Data as the No. 1 healthcare data solution for CRM and API integration, highlighting its API access and customer-specific cloud databases updated weekly.

AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both commercial and government applications, today announced significant progress toward bringing space-based cellular broadband to Brazil, Latin America’s largest economy.

Brixton Biosciences (Brixton), a clinical-stage life sciences company focused on developing a nerve-selective biomaterial designed to provide targeted and durable relief from pain, today announced the appointments of David Acheson as Chief Commercial Officer and Brian Newkirk as Chief Business Officer. The appointments strengthen Brixton's executive leadership team as the Company prepares for potential commercialization of its lead product, Reneurx™ Nerve-Selective Therapy for pain associated with knee osteoarthritis, with additional clinical and research initiatives focused on lateral hip pain, thumb joint pain and migraine.

Limited-edition Shadow Green FUGA DU 2 Trail Shoe Released

Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the voting results from its annual general and special meeting of shareholders convened on September 25, 2026, and adjourned to and reconvened on October 23, 2026 (the “Meeting”).

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Flotek Industries, Inc. (“Flotek” or “the Company”) (NYSE: FTK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Turning Point Brands, Inc. (NYSE: TPB) announced the date and time for its conference call to review third quarter 2026 results. The conference call will be on Monday, November 9th at 9:00 a.m. Eastern Time.

City Holding Company (“Company” or “City”) (NASDAQ:CHCO), a $6.8 billion bank holding company headquartered in Charleston, West Virginia, today announced net income of $34.6 million and record quarterly diluted earnings of $2.43 per share for the quarter ended September 30, 2026. For the quarter ended September 30, 2026, the Company achieved a return on assets of 2.03% and a return on tangible equity of 20.9%.

Light Chain Bioscience, a clinical-stage biotechnology company advancing the next generation of bispecific antibodies to treat cancer, today presented updated long-term results from a Phase 1/1b study of NI-1801 as a monotherapy and in combination with pembrolizumab in heavily pretreated Platinum Resistant Ovarian Cancer (PROC) patients that have no approved standard of care treatment. The data were reported in a Poster presentation at European Society of Medical Oncology (ESMO) Congress in Madrid.

Silversmith Capital Partners, a growth equity firm focused on supporting the best entrepreneurs in technology and healthcare, today announced the appointment of Jean Gulliver as Head of Investor Relations. In this role, Jean will lead the firm’s institutional investor relationships and capital formation efforts.

Acquisition adds battery-free smart wound dressing and two-minute multi-marker screening test to Davion’s growing healthcare portfolio

Nasdaq closes the minimum bid price matter confirming that the Company has regained compliance

- Ongoing Pivotal Phase 3 trial evaluating atebimetinib in combination with modified gemcitabine/nab-paclitaxel versus standard-of-care chemotherapy in first-line metastatic pancreatic cancer -

XTX501 is a novel PD-1/masked IL-2 bispecific that has the potential to become a foundational backbone regimen for solid tumors

Ahead of the UK clocks going back on 25 October 2026, SleepAids.com shares routine-based advice on adjusting bedtimes, limiting evening screens and preparing a calmer bedroom environment.

Every pairing features Traverse Bay Farms products, with simple ideas for quick appetizers, game day gatherings, holiday breakfasts and family dinners.

Nineteen holes totaling 3,350 meters tested VTEM conductors on the Goodwin Copper-Nickel-Cobalt Project in the Bathurst Mining Camp of New Brunswick; every completed hole intersected sulphide mineralization

For qualified laboratory buyers comparing research peptide suppliers, this review looks at Onyx BioLabs' publicly accessible batch reports, account-based pricing, and purchase terms before you order.Onyx BioLabs Peptides Reviews: What Should You Verify Beyond The COA Before Ordering?

United Kingdom, October 26, 2026 -- OnClarity, the end-to-end AI customer experience platform for large support organizations, today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network.

WILMINGTON, DELAWARE, Oct. 26, 2026 (GLOBE NEWSWIRE) -- CID HoldCo, Inc., doing business as Dot Ai (Nasdaq: DAIC) (“Dot Ai” or the “Company”), today announced the appointment of Avi Cohen to its Board of Directors. Cohen brings extensive experience leading technology companies through acquisitions, integration and expansion as Dot Ai enters its next phase of growth following the recent $65 million acquisition of its wholly owned subsidiary, Envoy Technologies.

Aliyyah Koloc and co-driver Marcin Pasek finished fifth overall at the Yecheng Rally, the last of three events in the Buggyra ZM Racing team’s Chinese campaign. The 22-year-old Czech driver and her Polish co-driver took their JJ3 T1+ car to fifth among 24 classified crews.

Drilling returns 616 g/t silver over 4.86 metres and intersects 23.60 metres of mineralization at the La Gloria-Abundancia vein junction

Haikou, Hainan, China, October 26, 2026 -- The "Tianya Teahouse" session of the "Let's Hainan" Media Salon kicked off on Oct. 23 in the atrium of the "Never-Ending" International Innovative Medical Devices Exhibition in Boao Lecheng. Guests sat among display cases of the latest approved medicines and devices, and between panels, tried singing-bowl healing and TCM diagnosis — the kind of wellness experience people now fly to Hainan for.

United States, October 26, 2026 -- Marci Veronie, Senior Vice President at Avemco Insurance Company, received the inaugural Board Chair's Award of Excellence at the 2026 Women in Aviation International Conference in Dallas, Texas.

Already available on Windows, macOS, Linux, ChromeOS, and as standalone browser extensions, DigitalZen now expands to Android, with iOS in development.

H2S Certification in North Dakota, Illinois, Oklahoma, Texas, Colorado, and Minnesota. H2S Training, HAZWOPER Certification, HAZWOPER Training Online, and HAZWOPER Refresher.

Beijing, China, October 26, 2026 -- Frame after frame of images witness the hand-in-hand pursuit of shared development; scene after scene of light and shadow freeze the warmth of heart-to-heart bonds; moment after moment demonstrates the responsibility of walking the same broad path together.

Beijing, China, October 26, 2026 -- The "Global South Dialogue: China-Indonesia Roundtable Forum," hosted by the Global Times, took place in Jakarta, Indonesia, on Monday, with more than 150 guests from various sectors in China and Indonesia engaging in in-depth discussions on topics such as building a China-Indonesia community with a shared future, strengthening China-ASEAN regional cooperation, and promoting the common development of the Global South.

ROCKVILLE, MD, Oct. 26, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced positive interim data from its ongoing Phase 2 LINNET study evaluating lorigerlimab, a bispecific DART® molecule that targets PD-1 and CTLA-4, in patients with CCGC. These Phase 2 data were presented today at the European Society for Medical Oncology (ESMO) 2026 Congress in Madrid, Spain. 

Third Quarter Highlights

Metropolitan Commercial Bank (“MCB” or the “Bank”), a full-service commercial bank headquartered in New York City, is proud to announce that it has been Certified™ by Great Place To Work® for the second year in a row, reaffirming the Bank's commitment to fostering an exceptional workplace culture where employees feel valued, supported, and empowered to succeed.

Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic imneskibart (AU-007), today presented positive Phase 2 data for imneskibart with avelumab in checkpoint inhibitor (CPI)-refractory adenocarcinoma non-small cell lung cancer (NSCLC). The data were shared in a poster session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain.

NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Serapha Bio, Inc. (Serapha), a clinical-stage genetic medicines company committed to transforming the treatment of alpha-1 antitrypsin deficiency (AATD), today announced early clinical data for YOLT-202 (SERP-01), an investigational one-time in vivo base editing therapy, from the ongoing investigator-initiated trial (IIT) evaluating its safety and efficacy in four participants with the PiZZ genotype. Simon Krooss, M.D., Ph.D. of Hannover Medical School presented the data at the European Respiratory Society Alpha-1 Antitrypsin Conference 2026, held on October 23-24 in Barcelona, Spain. The IIT is being conducted through a collaboration between Renji Hospital in Shanghai, China and Hannover Medical School in Germany.

The global Medical Device Security Market is projected to grow from USD 9046.21 million in 2026 to USD 22234.52 million by 2035, at a CAGR of 10.51%.

A new country on ISSCA's calendar extends the division's market-by-market Latin American education cadence.

RICHMOND, Va., Oct. 26, 2026 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (the “Company”), a Fortune 1000 company and one of the largest convenience store operators and wholesalers of fuel in the United States, today announced that the Company will host a conference call on Thursday, November 5, 2026 at 9:00 a.m. Eastern Time to discuss its financial results for the third quarter ended September 30, 2026.

Toronto, Ontario--(Newsfile Corp. - October 26, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical-stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of various cancers, bacteria and viruses, is providing an update on its Phase II Bacillus Calmette-Guérin ("BCG")-Unresponsive Non-Muscle Invasive Bladder Cancer ("NMIBC") Carcinoma In-Situ ("CIS") clinical study (with or without resected Ta/T1 papillary disease) ("Study II") and in addition its expanding oncology pipeline.

Management-Led Financing Includes Approximately $350,000 in Combined Participation from CEO Evan Gappelberg and CFO Anum Waqas

Available to everyone, the feature lets users request a generated tutorial video with their search. A new launch demo shows a question about black holes becoming a visual explanation.

FedEx Corp. (NYSE: FDX) today announced the appointment of Jamere Jackson as chief financial officer, effective Nov. 30. He succeeds Claude Russ, who has served as interim CFO since June 1.

The holidays should be about making memories, not making compromises. But with budgets stretched, busy schedules and growing shopping lists, customers are looking for ways to make the season special without added stress. Walmart is making it easier with three major holiday shopping events from November 12 through December 2, bringing savings on gifts, seasonal favorites and everyday essentials – plus a new holiday marketing campaign.

Genius Sports Limited (“Genius Sports”) (NYSE:GENI) today announced that it will release its third quarter 2026 results before 8:00AM ET on Thursday, November 5, 2026.

Braemar Hotels & Resorts Inc. (NYSE: BHR) (“Braemar” or the “Company”) today announced that its Board of Directors (the “Board”) intends to nominate eight highly qualified, seasoned leaders for election at the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”). The slate of eight director candidates includes seven new, highly qualified and independent director nominees:

Genmab A/S (Nasdaq: GMAB) today announced updated results from a Phase 2 trial evaluating petosemtamab, an investigational IgG1-bispecific antibody targeting the epidermal growth factor receptor (EGFR) and leucine-rich repeat containing G-protein-coupled receptor 5 (LGR5), in combination with pembrolizumab for first-line (1L) treatment of recurrent/metastatic PD-L1+ head and neck squamous cell carcinoma (r/m HNSCC). In the 1L combination arm, treatment with petosemtamab plus pembrolizumab achieved a median overall survival (OS) of 28.2 months, associated with an overall response rate (ORR) of 63% and median progression free survival (mPFS) of 9.0 months in efficacy-evaluable patients (n=43), including a complete response (CR) rate of 19%. The findings were presented at the European Society for Medical Oncology (ESMO) Congress 2026, held in Madrid, Spain.

Jack in the Box Inc. (NASDAQ: JACK) today announced that it will report fourth quarter and full-year fiscal 2026 financial results after market close on Wednesday, December 9, 2026.

RyCarma Therapeutics, Inc., a clinical-stage biotechnology company developing first-in-class small molecule therapeutics for skeletal muscle diseases, today announced that the first patient was dosed in a Phase 2 clinical trial of surlorian in patients with RYR1-related myopathy (RYR1-RM).

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that the first patient has been dosed in RESOLVE, its global Phase 2b/3 clinical trial of zelicapavir in adults at high risk of severe outcomes from RSV infection. Topline data from the Phase 2b portion of the study are expected in 2027.

First Farmers and Merchants Corporation (OTCID: FFMH), the holding company for First Farmers and Merchants Bank, today announced its results for the third quarter of 2026, reflecting continued growth and profitability, including robust 24.4% annualized loan growth, a 12.7% increase in net income, and an eleventh consecutive quarter of net interest margin expansion.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced new data that was recently presented at the American Society of Nephrology (ASN) Kidney Week 2026, highlighting the unique value genetic testing can provide for patients with CKD. These 18 abstracts, including three oral presentations, add to the growing support for Renasight, Natera’s genetic test for CKD.